Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, et al.
Developmental Cell (2023) Vol. 58, Iss. 12, pp. 1106-1121.e7
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1103-1117.e12
Open Access | Times Cited: 53
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Oncogenic Pathways and Targeted Therapies in Ovarian Cancer
Carolina Lliberos, Gary Richardson, Antonella Papa
Biomolecules (2024) Vol. 14, Iss. 5, pp. 585-585
Open Access | Times Cited: 9
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications
Colin D. Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries
Shiro Takamatsu, Kosuke Murakami, Noriomi Matsumura
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment
Haiyao Hu, Chongen Sun, Jingyao Chen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 3
Open Access | Times Cited: 6
Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
Yuqing Zhao, Chen Wang, Wei Deng, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 6
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
Qigu Yao, Sheng Cheng, Qiaoling Pan, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
Organoid: Bridging the gap between basic research and clinical practice
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 14
Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients
Huizi Wu, Weiwei Wang, Yinbin Zhang, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 2, pp. 324-338
Open Access | Times Cited: 5
Synthetic lethal interaction between WEE1 and PKMYT1 is a target for multiple low-dose treatment of high-grade serous ovarian carcinoma
Jan Benada, Daria Bulanova, Violette Azzoni, et al.
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 12
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells
Daria Bulanova, Yevhen Akimov, Wojciech Senkowski, et al.
Science Advances (2024) Vol. 10, Iss. 21
Open Access | Times Cited: 4
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
Jessica Kalla, Janette Pfneissl, Theresia Mair, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 4
Single-Cell RNA Sequencing in Ovarian Cancer: Current Progress and Future Prospects
Zhi Xiong Chong
Progress in Biophysics and Molecular Biology (2025)
Closed Access
Organoid development and applications in gynecological cancers: the new stage of tumor treatment
Yang Li, Meiying Qin, Ning Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1
Jing Yuan, Bumin Xie, Yu-Meng Ji, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
The atypical KRASQ22K mutation directs TGF‐β response towards partial epithelial‐to‐mesenchymal transition in patient‐derived colorectal cancer tumoroids
Theresia Mair, Philip König, Milena Mijović, et al.
Molecular Oncology (2025)
Open Access
Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells
Hui‐Yi Lin, Lingfang Wang, Hanwen Chen, et al.
Journal of Advanced Research (2025)
Open Access
Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids
Qi Cao, Chunhui Cai, Chen Wang, et al.
Phytomedicine (2025) Vol. 141, pp. 156721-156721
Closed Access
The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
Liuyue Kan, Yingyan Yu, Yan‐Jiang Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Emerging roles of 3D-culture systems in tackling tumor drug resistance
Amin Nikdouz, Francesca Orso
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 788-804
Open Access | Times Cited: 9
Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises
Aikaterini Skorda, Marie Lund Bay, Sampsa Hautaniemi, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6257-6257
Open Access | Times Cited: 16
Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
Wai Sun Chan, Xue-Tang Mo, Philip P.C. Ip, et al.
Cancer Medicine (2023) Vol. 12, Iss. 19, pp. 19714-19731
Open Access | Times Cited: 9
Can Nitric Oxide-Based Therapy Be Improved for the Treatment of Cancers? A Perspective
Birandra K. Sinha
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13611-13611
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top